Phase 3 study of Axiron for the treatment of hypogonadism - MPR
Links shared publicly online about this topic.
- 1,713total visits
Phase 3 study of Axiron for the treatment of hypogonadism - MPR
empr.com —
Acrux announced positive results from its Phase 3 trial of Axiron (testosterone topical solution 2%) for the treatment of testosterone deficiency (hypogonadism).
View full resource at empr.com
Tags: Hypogonadism, Phase 3 Clinical Trial, News
Most Recently Shared on September 29, 2009 at 9:39 pm By:
MPR News: Phase 3 study of Axiron for the treatment of hypogonadism: Acrux announced positive results .. http://bit.ly/4ofPmp
Newly Published Study Showed Axiron (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men - Drugs.com MedNews
drugs.com — “Eli Lilly and Company (NYSE LLY) announced that a pivotal Phase III Axiron study, published on the Clinical Endocrinology website, showed that Axiron (testoster” View full resource at drugs.com
Most Recently Shared on June 29, 2011 at 2:13 pm By:
Drugs and Devices OW OW Health
Newly Published Study Showed Axiron (testosterone) Topical Solution Restored Testosterone Levels to Normal... http://bit.ly/jQJ3no #drug
Advertisement
